F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

NEXT STORY
Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma
PREV STORY
Rhythm Pharmaceuticals to Present at the 59th Annual ESPE Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

author_avatar
NASDAQ Market News

Chembio Diagnostics to Participate in Upcoming Investor Conferences

author_avatar
NASDAQ Market News

Allogene Therapeutics Announces April 2019 Investor Conference Schedule 

author_avatar
NASDAQ Market News